STOCKHOLM, May 2, 2024
/PRNewswire/ -- SciBase Holding AB ("SciBase") (STO:
SCIB), a pioneer in skin cancer detection and prevention, and
prediction in dermatology, further deepens their
commitment to patients and dermatologists during US Skin Cancer
Awareness Month by highlighting the importance of early detection
and prevention of skin cancer and helping improve outcomes for
clinicians and patients.
The entire month of May is dedicated to Skin Cancer Awareness to
draw focus on the most common cancer in the United States - skin cancer. It is
estimated that more than 9,500 people are diagnosed with skin
cancer every day and over 200,000 people are diagnosed with
melanoma every year. Melanoma is the most dangerous and lethal form
of skin cancer and accounts for the vast majority of skin cancer
deaths. A good portion of these skin cancers may be prevented
if people were to protect their skin from the sun and tanning beds,
practice healthy skin habits, and visit a dermatologists at least
once a year for a full body skin exam. When detected early, skin
cancer is highly curable making early detection key to
survival.
"Melanoma is one of the top 10 most common cancers in the US.
With melanoma, early detection is vital to improving clinical
outcomes for patients. For these reasons, I am using the AI-powered
Nevisense test in my clinical practice. I recently performed a
Nevisense test on a mole that I was hesitant to biopsy, and the
technology provided me with real-time, non-invasive data right
there during that visit. I immediately integrated the Nevisense
data into my biopsy decision, and detected a melanoma in situ on
this patient much sooner than I would have otherwise. This
technology positively impacted the clinical outcome for both my
patient and for me as a clinician," said Dr. Brad Yentzer, Founder and CEO of Finger Lakes
Dermatology in New York.
"Most skin cancers are curable if they are detected and treated
early enough. Because of this, skin cancer education and the
importance of full body skin exams by board certified
dermatologists on patients at risk, are critical to early detection
and survival," said Dr. Mark
Kaufmann, Clinical Professor in the Department of
Dermatology at the Icahn School of Medicine at Mount Sinai, and
Chief Medical Officer of Advanced Dermatology and Cosmetic Surgery
in Florida, and former President
of The American Academy of Dermatology (2022-23).
"Early detection is key to improving patient outcomes and
survival. At SciBase, our emphasis on skin cancer awareness month
demonstrates how seriously we take the importance of patients
having an annual full body skin exam performed by a
dermatologist. We are deeply dedicated to supporting the early
detection of skin cancer at its most curable stage-when it matters
and can make a life-altering impact-and helping to improve outcomes
for clinicians and patients," said Pia
Renaudin, CEO of SciBase.
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802,
e-mail: pia.renaudin@scibase.com
Certified Advisor (CA):
Vator Securities
Tel: +46 8 580 065 99
Email: ca@vatorsec.se
About SciBase
SciBase is a global medical technology company, specializing in
early detection and prevention in dermatology. SciBase develops and
commercializes Nevisense, a unique point-of-care platform that
combines AI (artificial intelligence) and advanced EIS technology
to elevate diagnostic accuracy, ensuring proactive skin health
management.
Our commitment is to minimize patient suffering, allowing
clinicians to improve and save lives through timely detection and
intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in
dermatological advancements.
The company has been on the Nasdaq First North Growth Market
exchange since June 2, 2015. Learn
more at www.scibase.com. All press releases and financial
reports can be found here:
http://investors.scibase.se/en/pressreleases
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/scibase/r/scibase-supports-clinicians-during-us-skin-cancer-awareness-month,c3971723
View original
content:https://www.prnewswire.co.uk/news-releases/scibase-supports-clinicians-during-us-skin-cancer-awareness-month-302134142.html